Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.58, read 2026-11-03
Ethical does not pass the values gate
Price7.48 USD
Fair valueUnder review
Ethical score70.0/100
Our investment reviews on this name
2026-11-01Read Accumulation7.69-2.7% to today Markdown gives way to Accumulation after a 41% slide in 7 weeks
2026-09-11Read Markdown13.14-43.1% to today ✓Distribution gives way to Markdown with volume flow in agreement
2026-08-11Read Distribution13.14-43.1% to today ✓Markup gives way to Distribution after a 30% slide in 6 weeks
2026-07-02Read Markup18.75-60.1% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
RF Industries Ltd holds its Markdown at $7.48. Consolidating, no directional conviction, held for 4 days.
As held on the ledger · 2026-11-04
Phase
Markdown · caution
Quantitative state
Consolidating, no directional conviction, held for 4 days
Price at the screen
$7.48
Valuation
61.62 trailing · 9.00 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.28
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
36.40%
Below 33%
Interest-bearing debt is 36.4% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
27.31%
Below 49%
Money owed to the company is 27.3% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
RF Industries's business is in a permissible area, but its interest-bearing debt is about 36% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when RFIL's ethical verdict changes
Today RFIL does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Fair value under review. Only one analyst covers it, too few to cross-check it; our model's value is 2.33x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
RFIL trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-01Accumulation · changed$7.69+4.8%Entry 9
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 296%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (1 analysts) rates it hold, with a mean price target of $18.
2026-10-25Markdown$7.34+0.0%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bearish. Over the past year the shares are up 296%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (1 analysts) rates it hold, with a mean price target of $18.
2026-10-18Markdown$7.34-8.4%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 87% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 296%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (1 analysts) rates it hold, with a mean price target of $18.
2026-10-02Markdown$8.01-39.0%Entry 6
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 39.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 87% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 296%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (1 analysts) rates it hold, with a mean price target of $18.
2026-09-11Markdown · changed$13.14+0.0%Entry 5
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 87% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 296%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (1 analysts) rates it hold, with a mean price target of $18.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 29.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 87% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 296%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (1 analysts) rates it hold, with a mean price target of $18.
2026-07-18Markup$18.75+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 87% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 296%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (1 analysts) rates it hold, with a mean price target of $18.
2026-07-03Markup$18.75+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$18.75Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.